Thoughts have turned to shaping Framework Programme 8. Here, Stijn Delauré and Laura Keustermans of the League of European Research Universities make their recommendations.
Human genes are patentable, says the English Court of Appeal, but only if the patent describes a practical way that the gene or protein can be exploited.
Personalising medicine will improve healthcare and create important new markets. Europe needs to move now and seize the benefits it offers, writes Richard L. Hudson.
As the Commission prepares to set out translations rules for the European patent on May 18, here are some helpful suggestions from Bruno Van Pottelsberghe of the Bruegel think tank.